Literature DB >> 22773979

Relations between lymphangiogenesis and the size of pterygium.

Lin Liu1, Shi-Qi Ling, Qiao-Li Li, Tao Wang, Hui Ye, Jie-Zhen Yang, Xiu-Hua Jia.   

Abstract

AIM: To examine the relations between lymphangiogenesis and the size of pterygium.
METHODS: Tissues from 88 primary and 34 recurrent pterygia were evaluated, and those from 7 nasal epibulbar conjunctiva segments were used as controls. Pterygium slices from each patient were stained with LYVE-1 monoclonal antibodies to identify lymphatic microvessel for calculating lymph-vascular area (LVA), lymph-microvascular density (LMD) and lymph-vascular luminal diameter (LVL). Also, the relations between lymphangiogenesis (measuring by LVA, LMD and LVL) and the size of pterygium (extension, width and area) were explored.
RESULTS: There were a few LYVE-1((+)) lymphatic vessels in normal epibulbar conjunctiva segments. However, the number of lymphatic vessels slightly increased in primary pterygia and dramatically increased in recurrent pterygia. LVA, LMD and LVL significantly increased in recurrent pterygia in comparison with primary pterygia (all P<0.05). Both LMD and LVA were correlated with the width and area of pterygia (both P< 0.05), and LVA was also correlated with the extension of pterygia(P<0.05).
CONCLUSION: Lymphangiogenesis is correlated with the size of pterygium. The outgrowth of lymphatic vessels might contribute to the development of pterygia.

Entities:  

Keywords:  lymphatic vessel; pterygia; size

Year:  2012        PMID: 22773979      PMCID: PMC3388399          DOI: 10.3980/j.issn.2222-3959.2012.03.12

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  23 in total

Review 1.  The lymphatic vasculature in disease.

Authors:  Kari Alitalo
Journal:  Nat Med       Date:  2011-11-07       Impact factor: 53.440

Review 2.  Pterygium: its treatment with beta therapy.

Authors:  Juan Murube
Journal:  Ocul Surf       Date:  2009-01       Impact factor: 5.033

Review 3.  The science of pterygia.

Authors:  J C Bradley; W Yang; R H Bradley; T W Reid; I R Schwab
Journal:  Br J Ophthalmol       Date:  2009-06-09       Impact factor: 4.638

4.  An immunohistochemical analysis of fibroid vasculature.

Authors:  R Casey; P A Rogers; B J Vollenhoven
Journal:  Hum Reprod       Date:  2000-07       Impact factor: 6.918

5.  Preliminary evidence of the presence of lymphatic vessels immunoreactive for D2-40 and Prox-1 in human pterygium.

Authors:  Anca Maria Cimpean; Mihai Poenaru Sava; Marius Raica; Domenico Ribatti
Journal:  Oncol Rep       Date:  2011-06-08       Impact factor: 3.906

Review 6.  Biology of the lymphatic marker LYVE-1 and applications in research into lymphatic trafficking and lymphangiogenesis.

Authors:  David G Jackson
Journal:  APMIS       Date:  2004 Jul-Aug       Impact factor: 3.205

7.  High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer.

Authors:  Petri Bono; Veli-Matti Wasenius; Päivi Heikkilä; Johan Lundin; David G Jackson; Heikki Joensuu
Journal:  Clin Cancer Res       Date:  2004-11-01       Impact factor: 12.531

8.  Microarray and protein analysis of human pterygium.

Authors:  Molykutty John-Aryankalayil; Nicholas Dushku; Cynthia J Jaworski; Constance A Cox; Gregory Schultz; Janine A Smith; Keri E Ramsey; Dietrich A Stephan; Kenn A Freedman; Ted W Reid; Deborah A Carper
Journal:  Mol Vis       Date:  2006-01-23       Impact factor: 2.367

9.  Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed.

Authors:  Shiqi Ling; Caoxiu Qi; Wei Li; Jiangang Xu; Wenghui Kuang
Journal:  Clin Exp Ophthalmol       Date:  2009-12       Impact factor: 4.207

10.  Lymphangiogenesis and angiogenesis: concurrence and/or dependence? Studies in inbred mouse strains.

Authors:  Shintaro Nakao; Kazuichi Maruyama; Souska Zandi; Mark I Melhorn; Mahdi Taher; Kousuke Noda; Eyad Nusayr; Tom Doetschman; Ali Hafezi-Moghadam
Journal:  FASEB J       Date:  2009-10-26       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.